A biopharmaceutical company specializing in the discovery and development of next-generation peptide therapeutics using their proprietary Peptide Discovery Platform System (PDPS).
Company context
PeptiDream prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
PeptiDream is a leading Japanese biopharmaceutical company that specializes in the discovery and development of next-generation peptide therapeutics. Founded in 2006, the company has established itself as a global powerhouse in drug discovery, primarily through its proprietary Peptide Discovery Platform System (PDPS). This technology allows for the creation of highly diverse macrocyclic peptide libraries, enabling the development of potent therapeutic candidates, including peptide-drug conjugates and small-molecule drugs, to address significant unmet medical needs.
PeptiDream’s mission is to discover the next generation of transformational medicines to address unmet medical needs and improve the quality of life for patients worldwide.
Founded
2006
Headquarters
Kawasaki, Japan
Employees
700+
Industry
Biotechnology
Opportunity to work with cutting-edge, proprietary drug discovery technology
Strong financial stability and consistent growth through a robust partnership model
High pressure associated with meeting strict R&D milestones for global partners
Revenue
Not publicly disclosed
Funding
Publicly traded (TSE: 4587)
CEO
Patrick C. Reid
Complex organizational structure due to multiple subsidiaries and joint ventures